| Literature DB >> 35839163 |
José Antonio Mata-Marín1, Armando Abraham de Pablos-Leal1, Stefan Mauss2, Carla Ileana Arroyo-Anduiza3, Mara Soraya Rodríguez-Evaristo4, Luis Antonio Uribe-Noguéz5, María de Los Ángeles Berrospe-Silva6, Juan Carlos Lara-Castañeda7, Edgar Pérez-Barragán8, Jesús Gaytán-Martínez1.
Abstract
PURPOSE: In the last two decades transmission of hepatitis C virus (HCV) in HIV positive men who have sex with men (MSM) has been reported globally. Chemsex and specific sexual practices have been identified as risk factors. Our study aimed to identify risk factors for HCV transmission in MSM living with HIV attending in Mexico.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35839163 PMCID: PMC9286238 DOI: 10.1371/journal.pone.0269977
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Characteristics of the study population.
| Cases (81) | Controls (243) |
| |
|---|---|---|---|
| Age, median (IQR), years | 30.5 (18–52) | 28.8 (21–45) | 0.54 |
| CD4+, median (IQR) cells/mm3 | 498 (285–674) | 324 (212–499) | <0.001 |
| HIV viral load, median (IQR), copies/ mm3 | 51 (40–47347) | 15426 (6321–89363) | <0.001 |
| HCV viral load, median (IQR), copies/mm | 94326 (50–514500) | ||
| HCV seroconversion while on ART, n (%) | 18 (22.2) | ||
| Receiving ART, n (%) | 46 (56.7) | 11 (4) | |
| Genotype, n (%) | |||
| 1a, n (%) | 50 (79.3) | ||
| 1b, n (%) | 3 (4.7) | ||
| 2b, n (%) | 6 (9.5) | ||
| 4, n (%) | 2 (3.1) | ||
| 1a/4, n (%) | 2 (3.1) |
Abbreviations: ART: Antiretroviral therapy
Risk factors bivariate analysis.
| Risk Factor | OR | 95%CI | P Value |
|---|---|---|---|
| Age (>40 years) | 3.42 | 1.75–6.71 | <0.001 |
| IV Drugs | 2.63 | 1.05–6.6 | 0.03 |
| >5 Sex partners | 1.03 | 0.60–1.78 | 0.89 |
| Tattoos | 1.18 | 0.71–1.98 | 0.51 |
| Piercing | 1.94 | 1.1–3.2 | 0.01 |
| Surgery | 1.55 | 0.68–1.95 | 0.59 |
| Dental surgery | 0.82 | 0.49–1.35 | 0.44 |
| Colonoscopy | 1.87 | 0.82–4.27 | 0.13 |
| Acupuncture | 0.08 | 0.40–1.95 | 0.76 |
| Prision record | 0.59 | 0.06–5.16 | 0.63 |
| Chemsex | 1.52 | 0.91–2.56 | 0.17 |
| Cocaine | 3.36 | 1.80–6.27 | 0.01 |
| Sharing straw for cocaine inhalation | 4.28 | 1.35–13.52 | 0.01 |
| Use of gamma hydroxybutyrate (GHB) | 2.05 | 0.56–7.46 | 0.26 |
| Use of ketamine | 6.2 | 1.12–34.84 | 0.01 |
| Use of ecstasy | 1.99 | 0.06–4.60 | 0.09 |
| Use of marijuana | 2.10 | 1.24–3.58 | 0.005 |
| Use of methamphetamine | 2.09 | 1.01–4.32 | 0.04 |
| Use of poppers | 2.22 | 1.33–3.7 | 0.002 |
| Use of ethyl chloride | 2.67 | 1.29–5.56 | 0.007 |
| Alcohol use | 1.85 | 1.04–3.29 | 0.03 |
| Use of phosphodiesterase 5 inhibitors | 1.28 | 0.67–2.45 | 0.44 |
| Insertive fisting | 1.34 | 0.53–3.38 | 0.53 |
| Receptive fisting | 1.08 | 0.44–2.44 | 0.91 |
| Use of sex toys | 1.88 | 1.11–3.18 | 0.018 |
| Share Sex Toys | 6.19 | 2.33–16.42 | <0.001 |
| Group Sex | 1.95 | 1.11–3.25 | 0.009 |
| Enemas previous to sex (rectal douching) | 3.2 | 1.91–5.41 | <0.001 |
| Syphilis | 1.46 | 0.85–2.50 | 0.16 |
| Urethritis | 1.55 | 0.84–2.87 | 0.15 |
| HBV | 0.96 | 0.45–2.06 | 0.92 |
| HPV | 0.85 | 0.45–1.62 | 0.63 |
| Ulcerative genital infection | 1.30 | 0.69–2.4 | 0.40 |
| Proctitis | 1.47 | 0.63–3.40 | 0.36 |
Abbreviations: OR: Odds ratio; 95% CI: 95% confidence interval; HBV: Hepatitis B virus and HPV: Human papillomavirus
Multivariate analysis.
| Risk factors | aOR | 95%CI | P value |
|---|---|---|---|
| • Sharing straw for cocaine inhalation | 9.03 | 1.35–13.52 | 0.003 |
| • Sharing Sex Toys | 17.53 | 6.85–44.86 | 0.002 |
| • Ethyl chloride | 2.26 | 1.29–5.563 | 0.037 |
Abbreviations: aOR: adjusted odds ratio, 95% CI: 95% confidence interval